V/Q Scanning as First‑Line Imaging for Pulmonary Embolism in Patients with Iodinated Contrast Allergy

Clinical Assessment and D‑dimer Strategy

• Apply a validated clinical prediction rule (Wells or revised Geneva) to stratify pre‑test probability before any imaging. This step is essential for all patients, including those with contrast allergy. [European Respiratory Society] [1]

• In patients with low‑to‑intermediate clinical probability who are PERC‑positive, obtain a high‑sensitivity D‑dimer using age‑adjusted cut‑offs (age × 10 ng/mL for age > 50 years). A negative result safely excludes PE without the need for imaging. Evidence: prospective cohort studies. [European Society of Cardiology] [2]

• Do not use D‑dimer testing in patients with high clinical probability; proceed directly to V/Q scanning. A negative D‑dimer in this setting does not reliably rule out PE. Class I recommendation (strong evidence). [European Society of Cardiology] [3]

V/Q Scanning: Indications and Advantages

• V/Q scanning is the recommended first‑line diagnostic test for suspected PE in patients with a documented iodinated‑contrast allergy, after clinical probability assessment and appropriate D‑dimer testing. It avoids contrast exposure and has minimal contraindications. [European Respiratory Society; European Society of Cardiology] [1]4

• Radiation exposure from V/Q scanning is lower (~2 mSv) compared with CTPA (3–10 mSv). This benefit is particularly relevant for young patients and women of child‑bearing age. [European Respiratory Society; European Society of Cardiology] [1]4

• Patients in whom V/Q scanning is especially appropriate include those with a history of contrast‑medium‑induced anaphylaxis, severe renal impairment, young adults (especially females), pregnant women, and individuals with a normal chest radiograph. Evidence: guideline consensus. [European Respiratory Society; European Society of Cardiology] [1]4

Interpretation of V/Q Scan Results

• Report V/Q scans using a three‑tier classification: (1) normal, (2) high‑probability, and (3) non‑diagnostic/indeterminate. A normal scan has a 99 % negative predictive value for PE. [European Respiratory Society; European Society of Cardiology] [1]4

• A normal V/Q scan definitively excludes PE; no further testing or anticoagulation is required. This safety is confirmed by prospective outcome studies and randomized trials. Level A evidence. [European Respiratory Society; European Society of Cardiology] [1]4

• A high‑probability V/Q scan confirms PE in patients with intermediate or high clinical probability, though its positive predictive value is lower in low‑probability patients. Evidence: diagnostic accuracy studies. [European Respiratory Society; European Society of Cardiology] [1]4

• Non‑diagnostic V/Q scans occur in approximately 30–50 % of examinations. In such cases, lower‑extremity compression ultrasonography should be performed; a positive DVT result justifies anticoagulation. [European Respiratory Society; European Society of Cardiology] [1]4

Alternative Imaging and Adjunctive Tests

• V/Q SPECT (single‑photon emission CT) reduces the rate of non‑diagnostic scans to <3 % compared with planar V/Q scanning and may be preferred when available, although prospective outcome validation is lacking. Evidence: comparative imaging studies. [European Respiratory Society] [1]

Management of Non‑Diagnostic V/Q Scans

• When a V/Q scan is non‑diagnostic in patients with intermediate or high clinical probability, obtain lower‑extremity venous ultrasound. If the ultrasound is negative, consider repeat imaging in one week or multidisciplinary discussion regarding empiric anticoagulation. Evidence: management algorithms from cohort studies. [European Society of Cardiology] [2]3

• A documented history of contrast‑medium‑induced anaphylaxis constitutes a legitimate contraindication to CTPA and reinforces the need for V/Q scanning. Guideline consensus. [European Respiratory Society; European Society of Cardiology] [1]4

Ventilation-Perfusion Scan Guidelines for Suspected Pulmonary Embolism

Indications and Protocol

• The European Society of Cardiology recommends V/Q scanning as an alternative to CT pulmonary angiography in patients with contraindications to CT contrast or young patients to reduce radiation exposure 5, 6
• V/Q scanning is indicated in patients with a normal chest X-ray, as it has a higher proportion of diagnostic scans 5
• A current good quality chest radiograph should be available for comparison before performing a V/Q scan 7
• Clinical information, including Wells score or other validated clinical probability assessment, should be provided before interpreting V/Q scan results 8, 5

Technical Aspects and Interpretation

• Both ventilation and perfusion components should be performed for optimal diagnostic accuracy, but perfusion scanning alone may be acceptable in some cases 7
• Multiple views should be obtained to reduce the proportion of indeterminate scan reports 7
• V/Q scans should be reported using validated criteria, such as modified PIOPED criteria or PISA-PED reporting method 7
• Reports should categorize findings as normal, high probability, or non-diagnostic/indeterminate, with normal scans effectively ruling out PE and high probability scans confirming PE 8, 9, 7

Diagnostic Algorithm and Clinical Interpretation

• The European Society of Cardiology recommends assessing clinical probability of PE using validated prediction rules, measuring D-dimer, and proceeding with imaging if necessary 8, 5
• A normal V/Q scan excludes PE, while a high probability scan confirms PE 8, 9
• Non-diagnostic scans require further evaluation, including consideration of lower limb compression ultrasonography (CUS) 8, 5
• Patients with non-diagnostic scans and low clinical probability have a low prevalence of PE 5

Pitfalls and Limitations

• V/Q scan interpretation may be difficult or misleading in patients with previous pulmonary embolism, left heart failure, chronic obstructive airways disease, lung fibrosis, or proximal lung cancer 7
• Approximately 30-50% of V/Q scans are diagnostic, while the remainder may be non-diagnostic and require additional testing 8, 5

Diagnosing Pulmonary Embolism in Patients Allergic to Contrast Dye

Diagnostic Algorithm for PE in Contrast-Allergic Patients

• The European Society of Cardiology recommends ventilation-perfusion (V/Q) scanning as the first-line diagnostic test for patients with suspected pulmonary embolism who have allergies to contrast dye, providing accurate diagnosis without exposure to iodinated contrast media 10, 11
• For patients with low clinical probability, the American College of Physicians suggests applying PERC criteria (Pulmonary Embolism Rule-Out Criteria) to safely exclude PE without further testing 12
• A negative D-dimer test (ideally age-adjusted for patients >50 years) safely excludes PE in patients with low or intermediate clinical probability 12, 11
• V/Q scanning is the established first-line test for contrast-allergic patients, with few allergic reactions reported and lower radiation exposure compared to CT angiography 10, 11
• The European Heart Journal reports that pulmonary angiography has a risk of fatal complications approximately 0.1% and serious complications 1.5% 13
• Magnetic Resonance Angiography (MRA) has limited sensitivity and a high proportion of inconclusive scans, making it not yet ready for routine clinical practice 14